Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Novartis Ireland Limited, Vista Building, Elm Park, Merrion Road, Ballsbridge, Dublin 4, Ireland.
MOXIVIG 0.5% w/v eye drops, solution.
| Pharmaceutical Form |
|---|
|
Eye drops (solution). Clear, greenish-yellow solution. |
1 ml of solution contains 5.45 mg moxifloxacin hydrochloride (equivalent to 5 mg moxifloxacin).
Each eye drop contains 190 micrograms of moxifloxacin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Moxifloxacin |
Moxifloxacin, a fourth-generation fluoroquinolone, has in vitro activity against a wide range of Gram-positive and Gram-negative pathogens. The bactericidal action of moxifloxacin results from the inhibition of both type II topoisomerases (DNA gyrase and topoisomerase IV) required for bacterial DNA replication, transcription and repair. |
| List of Excipients |
|---|
|
Sodium chloride |
5 ml bottle with DROP-TAINER dispensing system consisting of a transparent low density polyethylene bottle and dispensing plug and white polypropylene closure. Tamper evidence is provided by a security seal around the closure of the bottle.
Pack size: box containing 1 bottle.
Novartis Ireland Limited, Vista Building, Elm Park, Merrion Road, Ballsbridge, Dublin 4, Ireland.
PL 23860/0016
Date of first authorisation: 27/07/2009
Date of last renewal: 29/04/2014
| Drug | Countries | |
|---|---|---|
| MOXIVIG | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
